| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
3,364 |
2,943 |
$31K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,570 |
3,299 |
$16K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,779 |
1,768 |
$10K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,845 |
2,631 |
$8K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,689 |
2,610 |
$5K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,103 |
1,100 |
$5K |
| 3078F |
|
5,456 |
4,911 |
$5K |
| 3074F |
|
4,179 |
3,801 |
$4K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
444 |
382 |
$4K |
| 99442 |
|
140 |
121 |
$3K |
| 93000 |
|
258 |
254 |
$2K |
| 3077F |
|
1,072 |
989 |
$2K |
| 3079F |
|
1,037 |
942 |
$1K |
| 1126F |
|
2,791 |
2,523 |
$1K |
| 3075F |
|
1,103 |
1,055 |
$1K |
| 1170F |
|
1,320 |
1,168 |
$1K |
| H0001 |
Alcohol and/or drug assessment |
2,647 |
2,608 |
$1K |
| 1160F |
|
6,006 |
5,325 |
$1K |
| 97802 |
|
3,049 |
2,656 |
$871.97 |
| 36415 |
Collection of venous blood by venipuncture |
4,534 |
4,366 |
$512.68 |
| 1125F |
|
1,684 |
1,583 |
$423.00 |
| 1159F |
|
3,394 |
3,128 |
$410.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
28 |
28 |
$351.03 |
| 81000 |
|
2,545 |
2,493 |
$327.31 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
13 |
13 |
$274.68 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
73 |
73 |
$163.14 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
202 |
200 |
$139.05 |
| 99401 |
|
130 |
103 |
$62.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
833 |
797 |
$48.55 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
142 |
142 |
$20.89 |
| 3051F |
|
329 |
310 |
$20.00 |
| 3044F |
|
680 |
673 |
$10.00 |
| 94760 |
|
978 |
969 |
$2.78 |
| 2010F |
|
6,789 |
5,958 |
$0.00 |
| 2001F |
|
1,563 |
1,472 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
2,388 |
2,109 |
$0.00 |
| 3011F |
|
800 |
794 |
$0.00 |
| G9275 |
Documentation that patient is a current non-tobacco user |
1,558 |
1,547 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
3,281 |
2,885 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
6,344 |
5,544 |
$0.00 |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
993 |
983 |
$0.00 |
| 1036F |
|
1,638 |
1,629 |
$0.00 |
| 2016F |
|
55 |
54 |
$0.00 |
| 3008F |
|
5,933 |
5,195 |
$0.00 |
| G8734 |
Elder maltreatment screen documented as negative, follow-up is not required |
1,271 |
1,113 |
$0.00 |
| G0432 |
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening |
483 |
483 |
$0.00 |
| 2000F |
|
1,782 |
1,648 |
$0.00 |
| 3049F |
|
136 |
135 |
$0.00 |
| 3017F |
|
222 |
221 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
64 |
56 |
$0.00 |
| 4293F |
|
668 |
665 |
$0.00 |
| 3754F |
|
32 |
31 |
$0.00 |
| 1220F |
|
232 |
217 |
$0.00 |
| 1101F |
|
1,170 |
1,025 |
$0.00 |
| 1000F |
|
931 |
905 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
336 |
299 |
$0.00 |
| 99000 |
|
575 |
565 |
$0.00 |
| 3048F |
|
236 |
235 |
$0.00 |
| 3061F |
|
597 |
592 |
$0.00 |
| 2015F |
|
55 |
54 |
$0.00 |
| 4010F |
|
15 |
15 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
247 |
225 |
$0.00 |
| 1005F |
|
55 |
54 |
$0.00 |
| 3014F |
|
119 |
118 |
$0.00 |
| 1006F |
|
33 |
33 |
$0.00 |
| 3052F |
|
15 |
14 |
$0.00 |
| 3060F |
|
40 |
40 |
$0.00 |
| 4144F |
|
55 |
54 |
$0.00 |
| 1034F |
|
17 |
17 |
$0.00 |
| 4086F |
|
38 |
38 |
$0.00 |
| 4140F |
|
55 |
54 |
$0.00 |
| 3725F |
|
4,351 |
3,931 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
6,958 |
5,999 |
$0.00 |
| G9621 |
Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling |
677 |
666 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
1,234 |
1,123 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
1,224 |
1,098 |
$0.00 |
| 4013F |
|
2,018 |
1,785 |
$0.00 |
| G9507 |
Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs) |
2,385 |
2,105 |
$0.00 |
| 1003F |
|
1,163 |
1,018 |
$0.00 |
| 3016F |
|
1,706 |
1,696 |
$0.00 |
| 99072 |
|
215 |
211 |
$0.00 |
| 0518F |
|
1,103 |
963 |
$0.00 |
| 2028F |
|
623 |
621 |
$0.00 |
| 3050F |
|
230 |
227 |
$0.00 |
| 3288F |
|
1,164 |
1,019 |
$0.00 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
1,830 |
1,572 |
$0.00 |
| 1090F |
|
1,166 |
1,021 |
$0.00 |
| 4025F |
|
55 |
54 |
$0.00 |
| 0556F |
|
495 |
491 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
222 |
197 |
$0.00 |
| G9383 |
Patient received screening for hcv infection within the 12 month reporting period |
508 |
507 |
$0.00 |
| G9820 |
Documentation of a chlamydia screening test with proper follow-up |
439 |
439 |
$0.00 |
| G9150 |
National committee for quality assurance - level 3 medical home |
39 |
39 |
$0.00 |
| 99397 |
|
155 |
155 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
13 |
13 |
$0.00 |
| 1158F |
|
127 |
127 |
$0.00 |
| 3015F |
|
75 |
73 |
$0.00 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
33 |
33 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
269 |
239 |
$0.00 |
| 1033F |
|
12 |
12 |
$0.00 |
| G8935 |
Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy |
12 |
12 |
$0.00 |